Last reviewed · How we verify
Celecoxib + Vitamin B fixed dose
Celecoxib + Vitamin B fixed dose is a Selective COX-2 inhibitor + B vitamin complex Small molecule drug developed by Laboratorios Silanes S.A. de C.V.. It is currently in Phase 3 development for Osteoarthritis, Rheumatoid arthritis, Acute pain conditions. Also known as: Cele+Vit B.
Celecoxib selectively inhibits cyclooxygenase-2 (COX-2) to reduce inflammation and pain, while B vitamins support metabolic and neurological function.
Celecoxib selectively inhibits cyclooxygenase-2 (COX-2) to reduce inflammation and pain, while B vitamins support metabolic and neurological function. Used for Osteoarthritis, Rheumatoid arthritis, Acute pain conditions.
At a glance
| Generic name | Celecoxib + Vitamin B fixed dose |
|---|---|
| Also known as | Cele+Vit B |
| Sponsor | Laboratorios Silanes S.A. de C.V. |
| Drug class | Selective COX-2 inhibitor + B vitamin complex |
| Target | COX-2 (cyclooxygenase-2) |
| Modality | Small molecule |
| Therapeutic area | Rheumatology / Pain Management |
| Phase | Phase 3 |
Mechanism of action
Celecoxib is a selective COX-2 inhibitor that reduces prostaglandin synthesis, thereby decreasing inflammation and pain without significantly affecting COX-1-mediated gastric protection. The fixed-dose combination with B vitamins (likely B1, B6, B12) aims to provide adjunctive neuroprotective and metabolic support, potentially reducing pain-related neurological symptoms and enhancing overall therapeutic benefit in inflammatory conditions.
Approved indications
- Osteoarthritis
- Rheumatoid arthritis
- Acute pain conditions
- Musculoskeletal pain with neuropathic component
Common side effects
- Gastrointestinal upset
- Headache
- Dizziness
- Hypertension
- Cardiovascular events (at higher doses/prolonged use)
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Celecoxib + Vitamin B fixed dose CI brief — competitive landscape report
- Celecoxib + Vitamin B fixed dose updates RSS · CI watch RSS
- Laboratorios Silanes S.A. de C.V. portfolio CI
Frequently asked questions about Celecoxib + Vitamin B fixed dose
What is Celecoxib + Vitamin B fixed dose?
How does Celecoxib + Vitamin B fixed dose work?
What is Celecoxib + Vitamin B fixed dose used for?
Who makes Celecoxib + Vitamin B fixed dose?
Is Celecoxib + Vitamin B fixed dose also known as anything else?
What drug class is Celecoxib + Vitamin B fixed dose in?
What development phase is Celecoxib + Vitamin B fixed dose in?
What are the side effects of Celecoxib + Vitamin B fixed dose?
What does Celecoxib + Vitamin B fixed dose target?
Related
- Drug class: All Selective COX-2 inhibitor + B vitamin complex drugs
- Target: All drugs targeting COX-2 (cyclooxygenase-2)
- Manufacturer: Laboratorios Silanes S.A. de C.V. — full pipeline
- Therapeutic area: All drugs in Rheumatology / Pain Management
- Indication: Drugs for Osteoarthritis
- Indication: Drugs for Rheumatoid arthritis
- Indication: Drugs for Acute pain conditions
- Also known as: Cele+Vit B
- Compare: Celecoxib + Vitamin B fixed dose vs similar drugs
- Pricing: Celecoxib + Vitamin B fixed dose cost, discount & access